Emerging modalities such as self-amplifying and circular RNA, expanding oncology and rare-disease applications, and scalable manufacturing are creating high-growth investment avenues, supported by ...
Driving RNA vaccine innovation through microbiome insights is an emerging frontier that moves beyond pathogen-only thinking and toward vaccines designed ...
The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...
The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...
Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.
Commissioner Marty Makary defended his agency's position and record on mRNA vaccines, days after it changed course and agreed ...
As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.
Singling out Health Secretary Robert F. Kennedy Jr.’s worst decision is difficult, because the competition is fierce, but near the top of the list was his decision to terminate a series of federal ...
TwistedSifter on MSN
New trial shows that an mRNA flu vaccine is over a third more effective than standard flu shots at preventing influenza A
A potential massive breakthrough!
A study reveals how two proteins cooperate in a key early step of antiviral detection, as reported by researchers at Science ...
Researchers show how LGP2 binds viral RNA ends, moves along the strand, and helps MDA5 form filaments that amplify antiviral signaling. The findings clarify an early defense step and may inform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results